Clinical Trials Browser

Phase NA × Constriction, Pathologic × 90 days × Clear all

NCT05149755 2026-05-19

Evolut™ EXPAND TAVR II Pivotal Trial

Phase NA Active not recruiting

Constriction, Pathologic, Lymphoma, Follicular